Fundraising Fox
Cleerly
Denver, US · Founded 2017 · 381 employees on LinkedIn · 20 known investors
Find your way into Cleerly
Sign up to see every warm intro you have to Cleerly
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cleerly team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease. Its technology, validated in peer-reviewed clinical trials, is used by healthcare organizations to support personalized treatment decisions in heart care.
Founders & leadership
Cleerly was founded in 2017 by James Min, MD.
Board
Investors · 20
How we know: Battery Ventures's portfolio page · funding news · mpo-mag.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Breyer Capital's portfolio page · cleerlyhealth.com · the VCSheet dataset · Not right? Tell us
How we know: Catalytic Impact Foundation's portfolio page · Not right? Tell us
How we know: cleerlyhealth.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Esplanade Ventures's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: Insight Partners's portfolio page · funding news · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: board seat on SEC Form D · cleerlyhealth.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: cleerlyhealth.com · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · cleerlyhealth.com · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 7
Funding
SEC filings, press & company announcements$380.9M disclosed across 5 of 7 rounds · 2017–2025
- Undisclosed amountSeries C extensionJan 2025
Insight Partners (lead), Battery Ventures
Source ↗ - Undisclosed amountSeries CDec 2024Source ↗
- $106MraisedDec 2024 · 3 sources
Insight Partners (lead)
Source ↗
▶$51.3MraisedDec 2024 · 10 investors · Other TechnologyRule 506(b)
- Lee CooperDirector
- Word D. Peake IIIDirector
- Peter Justin KleinDirector
- Scott BarclayDirector
- James K. MinExecutive Officer, Director
- Louis SamsonDirector
- Oscar MunozDirector
- Offering amount
- $106.3M
- Amount sold
- $51.3M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$192.3MraisedJul 2022 · 56 investors · Other TechnologyRule 506(b)
- Word D. PeakeDirector
- Peter Justin KleinDirector
- James K. MinExecutive Officer, Director
- Vijay LathiDirector
- Glenn SteeleDirector
- Roy BeveridgeDirector
- Kevin KingDirector
- Offering amount
- $230M
- Amount sold
- $192.3M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.8MraisedMar 2022 · 25 investors · Other TechnologyRule 506(b)
- James K. MinExecutive Officer, Director
- Word D. PeakeDirector
- Vijay LathiDirector
- Peter Justin KleinDirector
- Kevin KingDirector
- Kristin BinnsExecutive Officer
- Glenn SteeleDirector
- Nick NieslanikExecutive Officer
- Jim HartmanExecutive Officer
- Roy BeveridgeDirector
- James EarlsExecutive Officer
- Offering amount
- $16.8M
- Amount sold
- $16.8M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.5MraisedApr 2020 · 31 investors · Other TechnologyRule 506(b)
- James K. MinExecutive Officer, Director
- Offering amount
- $15.4M
- Amount sold
- $14.5M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Cleerly went on to found or lead other companies.
Frequently asked questions
- What does Cleerly do?
- Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease. Its technology, validated in peer-reviewed clinical trials, is used by healthcare organizations to support personalized treatment decisions in heart care.
- Who founded Cleerly?
- Cleerly was founded by James Min, MD in 2017.
- Who are Cleerly's investors?
- Cleerly's investors include Battery Ventures, Breyer Capital, Catalytic Impact Foundation, DigiTx Partners LLC, Esplanade Ventures, Insight Partners, LRVHealth, DCVC (Data Collective) and 5 more.
- How much funding has Cleerly raised?
- Cleerly has disclosed $380.9M raised across 5 of its 7 known rounds.
- Where is Cleerly headquartered?
- Cleerly is headquartered in Denver, US.